多瑞医药 (301075.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(多瑞医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 78,457,398.26334,299,367.07246,256,774.84170,393,701.0678,085,173.39401,049,788.47302,488,326.43185,038,350.9372,887,112.31
 营业利润(元) -3,502,991.0522,187,177.5420,138,145.5414,725,686.62-2,364,058.3321,256,288.8725,513,696.9615,470,201.509,381,414.07
 利润总额(元) -3,505,188.2622,248,828.6420,420,961.6415,018,990.43-2,331,674.1921,024,834.9925,395,400.5615,388,341.819,382,637.42
 净利润(元) -3,574,947.5417,091,722.1017,653,964.1413,407,483.10-2,520,711.1918,583,853.0121,603,579.6513,050,546.858,524,544.62
 归属于母公司股东的净利润(元) -2,537,276.1418,850,748.3419,310,802.0314,366,348.89-2,417,228.8320,502,175.0722,487,953.1513,832,403.608,912,462.89
盈利能力:
 销售毛利率(%) 39.4868.5570.8571.2764.7376.9878.8582.5586.78
 销售净利率(%) -4.565.117.177.87-3.234.637.147.0511.70
 净资产收益率(%) -0.342.472.521.89-0.31----
 总资产报酬率ROA(%) -0.331.801.731.38-0.41----
 投入资本回报率ROIC(%) -0.262.092.131.61-0.272.462.691.681.09
营运能力:
 存货周转率(次) 1.813.193.242.611.67----
 应收账款周转率(次) 1.013.953.112.221.10----
 总资产周转率(次) 0.080.340.250.190.09----
偿债能力:
 资产负债率(%) 28.4223.3723.7118.8018.6016.1814.6713.725.38
 股东权益比率(%) 67.1472.0071.9481.1081.2183.6185.0286.0094.41
 已获利息倍数(倍) -22.31-3.89-4.97-5.182.77-1.72-5.41-3.35-2.86
 流动比率 5.435.022.663.733.924.485.376.0015.30
 速动比率 4.914.542.353.443.734.205.085.7314.25
发展能力:
 营业收入增长率(%) 0.48-16.64-18.59-7.917.13-24.28-23.70-24.14-40.23
 营业利润增长率(%) -48.184.38-21.07-4.81-125.20-71.04-52.24-61.84-60.55
 税后利润增长率(%) -4.97-8.05-14.133.86-127.12-70.07-54.43-62.69-59.10
 净资产增长率(%) -0.992.733.213.12-4.78-5.22-2.49168.51200.95
 总资产增长率(%) 19.7719.2921.979.3610.705.570.64127.53121.49

前瞻产业研究院